Amedica Corp (AMDA):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Amedica Corp (AMDA) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7058
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Amedica Corp (Amedica) is a biomaterial company that develops, produces and markets medical-grade silicon nitride ceramics for spinal implants and arthroplasty applications. The company offers interbody fusion devices, pedicle screw systems, facet fixation systems. It also offers non-silicon nitride spinal fusion products, which are used in the treatment of deformity and degenerative spinal procedures. Amedica is advancing the development of corrosion-resistant hip and knee bearings and dental implants. The company caters to surgeons, hospitals, stocking distributors and private label customers. It distributes its products through a network of independent distributors and also through partnerships with original equipment manufacturers (OEMs)-in the US, Europe, China, Japan, Australia, Latin America and Canada. Amedica is headquartered in Salt Lake City, Utah, the US.

Amedica Corp (AMDA) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Amedica Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Amedica Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Amedica Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Amedica Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Amedica Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Amedica Corp, Medical Equipment, Deal Details 11
Venture Financing 11
Amedica Raises US$7.5 Million In Venture Financing 11
Amedica Raises US$3 Million In Venture Financing 12
Amedica Raises US$0.5 Million In Series F Financing 13
Amedica Raises US$30 Million In Venture Financing 14
Partnerships 15
Amedica Enters into Distribution Agreement with Weigao Orthopedic 15
Amedica Enters into Agreement with Celling Biosciences 16
Amedica Enters into Development Agreement with Worthington 17
Amedica Enters Into Distribution Agreement With K2M 18
Equity Offering 19
Amedica Raises USD15 Million in Public Offering of Units 19
Amedica Files Registration Statement for Rights Offering of Units for up to USD11.4 Million 20
Amedica Raises USD4.5 Million in Public Offering of Shares and Warrants 21
Amedica Plans to Raise Funds through Public Offering of Shares 23
Amedica Raises USD12.7 Million in Public Offering of Units 24
Amedica Raises USD5 Million in First Tranche of Equity Financing 26
Amedica Raises USD13 Million in Public Offering of Units 28
Amedica Completes IPO For US$20 Million 29
Debt Offering 30
Amedica Raises USD2.5 Million in Private Placement of Notes and Warrants 30
Asset Transactions 31
CTL Medical Acquires Spine Business from Amedica for USD10 Million 31
Amedica Corp – Key Competitors 32
Amedica Corp – Key Employees 33
Amedica Corp – Locations And Subsidiaries 34
Head Office 34
Recent Developments 35
Financial Announcements 35
Sep 22, 2017: Amedica Releases First and Second Quarter 2017 Preliminary Unaudited Earnings Report and Business Update 35
Jun 08, 2017: Amedica Releases 2016 Preliminary Earnings Report and Business Update 37
Legal and Regulatory 39
Mar 15, 2018: Amedica Granted Extension by NASDAQ to Regain Compliance with NASDAQ Listing Rule 39
Dec 01, 2017: Amedica Receives Positive Nasdaq Listing Decision 40
Aug 25, 2017: Amedica receives Nasdaq listing determination; Plans to request hearing 41
Product News 42
Apr 24, 2017: Amedica Announces Regulatory Clearance to Market and Sell Valeo Silicon Nitride Spinal Implants in Australia 42
Feb 27, 2017: Amedica Announces Results of Independent Femoral Head Wear Testing 43
Other Significant Developments 44
May 08, 2018: Amedica Provides Update on its Clinical Studies 44
Jan 25, 2018: Amedica provides business update 45
Apr 19, 2017: Amedica Announces Delayed Filing of Annual Report on Form 10-K and Receipt of Nasdaq Letter 47
Appendix 48
Methodology 48
About GlobalData 48
Contact Us 48
Disclaimer 48

List of Tables
Amedica Corp, Medical Equipment, Key Facts, 2017 2
Amedica Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Amedica Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Amedica Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Amedica Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Amedica Corp, Deals By Market, 2012 to YTD 2018 9
Amedica Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Amedica Raises US$7.5 Million In Venture Financing 11
Amedica Raises US$3 Million In Venture Financing 12
Amedica Raises US$0.5 Million In Series F Financing 13
Amedica Raises US$30 Million In Venture Financing 14
Amedica Enters into Distribution Agreement with Weigao Orthopedic 15
Amedica Enters into Agreement with Celling Biosciences 16
Amedica Enters into Development Agreement with Worthington 17
Amedica Enters Into Distribution Agreement With K2M 18
Amedica Raises USD15 Million in Public Offering of Units 19
Amedica Files Registration Statement for Rights Offering of Units for up to USD11.4 Million 20
Amedica Raises USD4.5 Million in Public Offering of Shares and Warrants 21
Amedica Plans to Raise Funds through Public Offering of Shares 23
Amedica Raises USD12.7 Million in Public Offering of Units 24
Amedica Raises USD5 Million in First Tranche of Equity Financing 26
Amedica Raises USD13 Million in Public Offering of Units 28
Amedica Completes IPO For US$20 Million 29
Amedica Raises USD2.5 Million in Private Placement of Notes and Warrants 30
CTL Medical Acquires Spine Business from Amedica for USD10 Million 31
Amedica Corp, Key Competitors 32
Amedica Corp, Key Employees 33

List of Figures
Amedica Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Amedica Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Amedica Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Amedica Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Amedica Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Amedica Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Amedica Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Amedica Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Amedica Corp (AMDA):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • American Bio Medica Corp (ABMC):企業の製品パイプライン分析2018
    Summary American Bio Medica Corp (ABMC) is a biotechnology company that develops, manufactures and markets immunoassay test kits. The company’s products include Rapid TOX, a point of collection testing product that detects 1-10 drugs of abuse in a urine specimen; Rapid One, a test cassette which is …
  • Koninklijke Wessanen N.V.:企業のM&A・事業提携・投資動向
    Koninklijke Wessanen N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Koninklijke Wessanen N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • International Drug Development Institute-製薬・医療分野:企業M&A・提携分析
    Summary International Drug Development Institute (IDDI) is a healthcare institute that offers clinical data collection, analysis, trial design and trial reporting services. The institute offers biostatistical services and eClinical services and risk-based monitoring programs. Its biostatistical and …
  • HDFC Standard Life Insurance Company Limited:企業のM&A・事業提携・投資動向
    HDFC Standard Life Insurance Company Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HDFC Standard Life Insurance Company Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, d …
  • Dune Medical Devices Ltd:企業の製品パイプライン分析2018
    Summary Dune Medical Devices Ltd (Dune Medical), a subsidiary of Dune Medical Devices Inc, is a medical device company that offers diagnostic products. The company develops, manufactures, and commercializes tissue characterization devices including MarginProbe system that provides assessment of the …
  • Linde AG (LIN)-製薬・医療分野:企業M&A・提携分析
    Summary Linde AG (Linde) is a provider of industrial gases and engineering services. The company specializes in the planning, procurement, construction and operation of gas production and processing plants. Linde offers a wide range of compressed and liquefied gases, and chemicals, and offers facili …
  • InterHealth Nutraceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary InterHealth Nutraceuticals Inc (InterHealth), a subsidiary of Lonza Group Ltd, is a developer, manufacturer and distributor of nutraceutical ingredients. The company offers nutritional ingredients such as Zychrome, Meratrim, LOWAT, Super CitriMax, ChromeMate, L-OptiZinc, Protykin, ZMA, UC-II …
  • Otter Tail Corp:企業の発電所・SWOT分析2018
    Otter Tail Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • Slavneft-Megionneftegaz (MFGS):企業の財務・戦略的SWOT分析
    Summary Slavneft-Megionneftegaz (Megionneftegaz), a subsidiary of Slavneft, is an oil and gas company that operates oil fields. The company’s activities include appraisal of oil and gas fields, oil and gas production, and well drilling and operation. Megionneftegaz develops and introduces advanced t …
  • Logan Resources Ltd:企業の戦略・SWOT・財務情報
    Logan Resources Ltd - Strategy, SWOT and Corporate Finance Report Summary Logan Resources Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • ARC Resources Ltd (ARX):企業の財務・戦略的SWOT分析
    ARC Resources Ltd (ARX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • CardioGenics Inc:企業の製品パイプライン分析2018
    Summary CardioGenics Inc (CardioGenics), a subsidiary of CardioGenics Holdings Inc is a medical device company that manufactures sensitive diagnostic test products to the in-vitro diagnostics market. The company’s products include QL care analyzer, immunoassay tests, and paramagnetic beads, among ot …
  • Millicom International Cellular SA (MIC SDB):企業の財務・戦略的SWOT分析
    Millicom International Cellular SA (MIC SDB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stren …
  • Do & Co Poland Sp.Z.O.O
    Do & Co Poland Sp.Z.O.O - Strategy, SWOT and Corporate Finance Report Summary Do & Co Poland Sp.Z.O.O - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Dance Biopharm Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Dance Biopharm Inc (Dance Biopharm), a subsidiary of Dance Biopharm Holdings Inc, formerly Dance Pharmaceuticals Inc, is a biotechnology company that develops inhaled insulin products to treat diabetes patients. The company provides product pipeline such as Dance-501, a pocket-sized inhaler …
  • Ems-Chemie Holding AG (EMSN):企業の財務・戦略的SWOT分析
    Summary Ems-Chemie Holding AG (Ems-Chemie), a subsidiary of Emesta Holding AG, is a chemical company. The company manufactures and markets high performance polymers and specialty chemicals. Its products include bonding products, polyamides, damping systems, sealants, and coating products. Ems-Chemie …
  • Meghmani Organics Ltd (MEGH):企業の財務・戦略的SWOT分析
    Summary Meghmani Organics Ltd (Meghmani Organics) is a chemical product manufacturing company. The company develops, produce and markets pigments and pesticides. Its pigments include pigments for plastics, pigments for printing inks and pigments for coatings. Meghmani Organics’ pesticides comprise f …
  • Capstone Turbine Corp (CPST):企業の財務・戦略的SWOT分析
    Capstone Turbine Corp (CPST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • SurgaColl Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary SurgaColl Technologies Ltd (SurgaColl Technologies) is a medical device company that develops novel tissue regeneration products for the surgical treatment of disease of the bone, cartilage and other human tissue. The company’s products include hydroxycoll and chondrocoll. Its hydroxycoll is …
  • Credit Guarantee Insurance Corporation of Africa Ltd:企業の戦略・SWOT・財務分析
    Credit Guarantee Insurance Corporation of Africa Ltd - Strategy, SWOT and Corporate Finance Report Summary Credit Guarantee Insurance Corporation of Africa Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's st …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆